Tivdak
Chemical Name | tisotumab vedotin-tftv |
Dosage Form | Lyophilized powder (intravenous; 40 mg) |
Drug Class | Inhibitors |
System | Female reproductive |
Company | Seagen |
Approval Year | 2021 |
Indication
- For the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy